Pfizer also did good business in the first quarter of this year with the corona vaccine that the pharmaceutical company developed together with biotech company BioNTech.
Both the turnover and profit of the American company skyrocketed. The corona pill that the company introduced also contributed to this.
In total, Pfizer sold 25.7 billion dollars worth of medicines. That is an increase of 77 percent compared to last year when the delivery of corona vaccines had just started. As a result, profits came in at $7.9 billion, 61 percent more than a year earlier.
According to CEO Albert Bourla, Pfizer is well on track to deliver at least 2 billion doses of the corona vaccine to poor and developing countries this year and next. In addition, the production of the corona medicine Paxlovid is also in line with the schedule.
Pfizer has decided to remain active in the Russian market because the company focuses on promoting people’s health and, therefore, Russians. In addition, the profits of Russian daughters are donated to charities in Ukraine.
